SCHEMBL139434

SCHEMBL139434

CCCCOC(=O)C(C)=O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.65
TSHR P16473 5/20 0.57
ATM Q13315 1/20 0.54
HPGD P15428 1/20 0.50
HCAR2 Q8TDS4 1/20 0.47
NAAA Q02083 1/20 0.46
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
RAD52 P43351 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
EPHX1 P07099 1/20 0.43
LMNA P02545 1/20 0.42
ESR1 P03372 1/20 0.42
CYP1A2 P05177 1/20 0.42
CYP2D6 P10635 1/20 0.42
MAPK1 P28482 1/20 0.42
CYP2C19 P33261 1/20 0.42
NR1H2 P55055 1/20 0.42
RNASEL Q05823 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6300117 0.95 ALDH1A1 (0.60) ALDH1A1TSHRATMHPGDHCAR2
SCHEMBL1083216 0.93 TSHR (0.67) ALDH1A1TSHRATMHCAR2NAAA
SCHEMBL919347 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL22607980 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL521587 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL22647791 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL22647724 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL22647718 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL3018392 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52
SCHEMBL6562247 0.91 TSHR (0.70) ALDH1A1TSHRHCAR2NAAARAD52

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1404 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120004771-A Method for producing organic sulfinate compound 中国石油化工股份有限公司 2025-05-16 CN claimed
CN-117983277-B Preparation method and application of catalyst for oxidative dehydrogenation of hydroxyl-containing compound 常州大学 2024-10-01 CN claimed
US-20240166679-A1 USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS LYGG CORPORATION 2024-05-23 US claimed
CN-117983277-A Preparation method and application of catalyst for oxidative dehydrogenation of hydroxyl-containing compound 常州大学 2024-05-07 CN claimed
EP-4329743-A1 PYRUVATE ESTERS FOR THE TREATMENT OF VIRAL DISEASES Birkenmeier, Gerd (DE) 2024-03-06 EP claimed
EP-4301831-A1 USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS LYGG Corporation (US) 2024-01-10 EP claimed
CN-117222726-A Use of ketoacids for stabilizing lignin in lignocellulosic biomass extraction processes 理革公司 2023-12-12 CN claimed
US-11822250-B2 Solution, method of forming resist pattern, and semiconductor device manufacturing method TOKYO OHKA KOGYO CO., LTD. (JP) 2023-11-21 US claimed
CN-116115811-A Composition for removing peculiar smell 广东爱车小屋电子商务科技有限公司 2023-05-16 CN claimed
WO-2022228652-A1 MEANS AND METHOD FOR TREATING VIRAL INFECTIONS BIRKENMEIER GERD (DE) 2022-11-03 WO claimed
US-20050059738-A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion XANTHUS LIFE SCIENCES, INC. (CA) 2005-03-17 US claimed
EP-1233767-A4 PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION XANTHUS LIFE SCIENCES INC (CA) 2005-02-09 EP claimed
CN-1514724-A Parasiticide for fish farming 第一制网株式会社 2004-07-21 CN claimed
US-20030073743-A1 Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion XANTHUS LIFE SCIENCES, INC. (CA) 2003-04-17 US claimed
EP-1097917-B1 Preparing method of alpha-ketocarboxylic acid derivatives KOREA RES INST CHEM TECH (KR) 2003-02-12 EP claimed
CN-1377266-A Pyruvate ester composition and method of use for resuscitation after events of ischemia and reperfusion MASSTRACE INC (CA) 2002-10-30 CN claimed
EP-1233767-A1 PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION Xanthus Life Sciences, Inc. (CA) 2002-08-28 EP claimed
EP-1097917-A1 Preparing method of alpha-ketocarboxylic acid derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2001-05-09 EP claimed
WO-2001030741-A1 PREPARING METHOD OF ALPHA-KETOCARBOXYLIC ACID DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2001-05-03 WO claimed
WO-2001024793-A1 PYRUVATE ESTER COMPOSITION AND METHOD OF USE FOR RESUSCITATION AFTER EVENTS OF ISCHEMIA AND REPERFUSION XANTHUS LIFE SCIENCES, INC. (CA) 2001-04-12 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240166679-A1 USE OF KETOACIDS FOR LIGNIN STABILIZATION DURING EXTRACTION FROM LIGNOCELLULOSIC BIOMASS KHK, LCT, HOGA1 ALDH1A1 855/4885TSHR 4839/4885ATM 2439/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.